Research Article

Clinicopathologic Features of Phyllodes Tumor in Breast

Volume: 22 Number: 2 August 30, 2020
TR EN

Clinicopathologic Features of Phyllodes Tumor in Breast

Abstract

Aim: Phyllodes tumors are rare breast neoplasms comprising less than 1% of all breast neoplasms. The objective of this study was to consider the clinicopathological features of phyllodes tumors that underwent surgery in our hospital.
Material and Methods: We retrospectively analyzed the medical records of 16 patients who had histologically diagnosed phyllodes tumors over 9 years.
Results: There were 16 female patients with a mean age of 45.6±15.3 years. Magnetic resonance imaging was performed in 5 cases for preoperative diagnosis, and 4 were reported as phyllodes tumors, all of these patients were having high-grade phyllodes tumors (borderline or malignant) histopathologically. Preoperative core biopsy was performed in 14 patients, and histopathologically phyllodes tumor was diagnosed in two patients. In six patients, differentiation between hypercellular fibroadenoma and phyllodes tumor could not be performed. Breast-conserving surgery was the most common type of operation performed in 10 (62.5%) patients, three patients with positive margins were underwent reoperation. The pathological diagnoses were benign, borderline, and malignant in seven (43.8%), five (31.3%) and four (25.0%) patients, respectively. The median diameter of the tumors was measured as 6 cm after the postoperative pathological analysis. The median follow-up time was 36 months. During this time, there was no local or systemic recurrence.
Conclusion: Wide excision with a clear margin appears to be the most important factor in the management of these tumors and in the prevention of local recurrence. The preoperative diagnosis of phyllodes tumors contributes to decreasing the necessity for secondary surgical intervention avoiding border positivity.

Keywords

References

  1. Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107(9):2127-33.
  2. Ditsatham C, Chongruksut W. Phyllodes tumor of the breast: diagnosis, management and outcome during a 10-year experience. Cancer Manag Res. 2019;11:7805-11.
  3. Chen WH, Cheng SP, Tzen CY, Yang TL, Jeng KS, Liu CL, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185-94.
  4. Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77(5):910-6.
  5. Ang MK, Ooi AS, Thike AA, Tan P, Zhang Z, Dykema K, et al. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression. Breast Cancer Res Treat. 2011;129(2):319-29.
  6. Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009;16(8):2288-94.
  7. Hassouna JB, Damak T, Gamoudi A, Chargui R, Khomsi F, Mahjoub S, et al. Phyllodes tumors of the breast: a case series of 106 patients. Am J Surg. 2006;192(2):141-7.
  8. Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am J Surg Pathol, 1998,22(1):64-9.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

August 30, 2020

Submission Date

March 28, 2020

Acceptance Date

June 5, 2020

Published in Issue

Year 2020 Volume: 22 Number: 2

APA
Karagöz Eren, S., Dönder, Y., Ertan, T., Akay, E., & Arslan, A. (2020). Clinicopathologic Features of Phyllodes Tumor in Breast. Duzce Medical Journal, 22(2), 91-95. https://doi.org/10.18678/dtfd.710317
AMA
1.Karagöz Eren S, Dönder Y, Ertan T, Akay E, Arslan A. Clinicopathologic Features of Phyllodes Tumor in Breast. Duzce Med J. 2020;22(2):91-95. doi:10.18678/dtfd.710317
Chicago
Karagöz Eren, Saliha, Yunus Dönder, Tamer Ertan, Ebru Akay, and Alaettin Arslan. 2020. “Clinicopathologic Features of Phyllodes Tumor in Breast”. Duzce Medical Journal 22 (2): 91-95. https://doi.org/10.18678/dtfd.710317.
EndNote
Karagöz Eren S, Dönder Y, Ertan T, Akay E, Arslan A (August 1, 2020) Clinicopathologic Features of Phyllodes Tumor in Breast. Duzce Medical Journal 22 2 91–95.
IEEE
[1]S. Karagöz Eren, Y. Dönder, T. Ertan, E. Akay, and A. Arslan, “Clinicopathologic Features of Phyllodes Tumor in Breast”, Duzce Med J, vol. 22, no. 2, pp. 91–95, Aug. 2020, doi: 10.18678/dtfd.710317.
ISNAD
Karagöz Eren, Saliha - Dönder, Yunus - Ertan, Tamer - Akay, Ebru - Arslan, Alaettin. “Clinicopathologic Features of Phyllodes Tumor in Breast”. Duzce Medical Journal 22/2 (August 1, 2020): 91-95. https://doi.org/10.18678/dtfd.710317.
JAMA
1.Karagöz Eren S, Dönder Y, Ertan T, Akay E, Arslan A. Clinicopathologic Features of Phyllodes Tumor in Breast. Duzce Med J. 2020;22:91–95.
MLA
Karagöz Eren, Saliha, et al. “Clinicopathologic Features of Phyllodes Tumor in Breast”. Duzce Medical Journal, vol. 22, no. 2, Aug. 2020, pp. 91-95, doi:10.18678/dtfd.710317.
Vancouver
1.Saliha Karagöz Eren, Yunus Dönder, Tamer Ertan, Ebru Akay, Alaettin Arslan. Clinicopathologic Features of Phyllodes Tumor in Breast. Duzce Med J. 2020 Aug. 1;22(2):91-5. doi:10.18678/dtfd.710317